+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dry Powder Inhaler"

From
From
From
From
From
From
From
From
From
Aerosol Delivery Devices Market Report 2024 - Product Thumbnail Image

Aerosol Delivery Devices Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
Digital Dose Inhalers - Global Strategic Business Report - Product Thumbnail Image

Digital Dose Inhalers - Global Strategic Business Report

  • Report
  • March 2025
  • 507 Pages
  • Global
From
Respiratory Inhalers - Global Strategic Business Report - Product Thumbnail Image

Respiratory Inhalers - Global Strategic Business Report

  • Report
  • March 2025
  • 620 Pages
  • Global
From
From
Smart Inhalers Market Report 2025 - Product Thumbnail Image

Smart Inhalers Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Bronchodilators Market Report 2025 - Product Thumbnail Image

Bronchodilators Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Dry Powder Inhaler Market Report 2025 - Product Thumbnail Image

Dry Powder Inhaler Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Respiratory Inhaler Devices Market Report 2025 - Product Thumbnail Image

Respiratory Inhaler Devices Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Loading Indicator

The Dry Powder Inhaler (DPI) market is a segment of the respiratory drugs market. It is a device used to deliver medication to the lungs in the form of a dry powder. It is a convenient and efficient way to deliver medication to the lungs, as it does not require the use of a propellant gas. DPIs are used to treat a variety of respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. They are also used to deliver vaccines and other medications. DPIs are becoming increasingly popular due to their convenience and effectiveness. They are also cost-effective, as they require fewer components than other inhalers. Additionally, DPIs are easy to use and can be used by patients of all ages. Several companies are involved in the DPI market, including GlaxoSmithKline, Boehringer Ingelheim, Novartis, Merck, and AstraZeneca. These companies are involved in the development, manufacture, and marketing of DPIs. Show Less Read more